Unite de Fabrication de Medicaments SA (UMED)

Tunis

Currency in TND

7.10

-0.04(-0.56%)

Closed07:59:59

Fair Value

Day's Range

7.10

7.15

52 wk Range

6.17

7.57

UMED Income Statement

Featured here, the Income Statement (earnings report) for Unite de Fabrication de Medicaments SA, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

107.21

91.04

84.51

96.36

136

Total Revenues Growth

+23.1%

-15.07%

-7.18%

+14.02%

+41.14%

Cost Of Revenues

48.54

43.69

38.22

46.8

61.72

Gross Profit

58.67

47.35

46.29

49.56

74.29

Gross Profit Growth

+13.66%

-19.29%

-2.24%

+7.05%

+49.9%

Gross Profit Margin %

54.72%

52.01%

54.78%

51.43%

54.62%

Other Operating Expenses, Total

29.86

34.03

32.55

35.95

45.18

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+8.94%	+13.94%	-4.35%	+10.45%	+25.67%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14.99	15.1	15.48	16.77	19.71
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7.72	8.37	6.87	8.27	9.88

Operating Income

28.8

13.33

13.74

13.61

29.11

Operating Income Growth

+18.99%

-53.73%

+3.14%

-0.98%

+113.9%

EBIT Margin %

26.87%

14.64%

16.26%

14.12%

21.4%

Net Interest Expenses

-3.92

-3.73

-2.34

-3.41

-6.13

Net Interest Expenses Growth

-268.87%

+4.75%

+37.18%

-45.37%

-79.84%

Interest Expense, Total

-3.93

-3.74

-2.63

-3.6

-6.22

Interest And Investment Income

0.01

0.01

0.28

0.19

0.09

Other Non Operating Expenses, Total

-2.8

-0.36

-0.93

-0.26

-11.78

EBT, Excl. Unusual Items

22.08

9.23

10.47

9.94

11.21

Gain (Loss) On Sale Of Assets

0.03

0.08

0.04

0.09

0.08

Other Unusual Items, Total

-0.01

-0.04

-0.08

-0.2

-0.3

EBT, Incl. Unusual Items

22.09

9.27

10.43

9.83

10.99

EBT, Incl. Unusual Items Growth

-3.41%

-58.02%

+12.42%

-5.7%

+11.84%

EBT, Incl. Unusual Items Margin

20.61%

10.19%

12.34%

10.2%

8.08%

Income Tax Expense

4.4

2.29

1.72

2

5.45

Net Income to Company

17.69

6.98

8.7

7.83

5.55

Minority Interest

-

-

-

-

-

Net Income

17.69

6.98

8.7

7.83

5.55

Net Income Growth

-3.64%

-60.55%

+24.69%

-10.03%

-29.17%

Net Income Margin %

16.5%

7.67%

10.3%

8.13%

4.08%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

17.69

6.98

8.7

7.83

5.55

Basic EPS - Continuing Operations

0.55

0.22

0.27

0.24

0.17

Basic EPS - Continuing Operations Growth

-3.64%

-60.55%

+24.69%

-10.03%

-29.17%

Diluted EPS - Continuing Operations

0.55

0.22

0.27

0.24

0.17

Diluted EPS - Continuing Operations Growth

-3.64%

-60.55%

+24.69%

-10.03%

-29.17%

Basic Weighted Average Shares Outstanding

32

32

32

32

32

Diluted Weighted Average Shares Outstanding

32

32

32

32

32

Dividend Per Share

-

-

0.41

0.47

-

Dividend Per Share Growth

-

-

-

+15.52%

-

EBITDA

35.8

22.79

23.02

23.3

39.11

EBITDA Growth

+18.11%

-36.34%

+1.01%

+1.24%

+67.81%

EBITDA Margin %

33.39%

25.03%

27.24%

24.18%

28.75%

EBIT